STATCenter·
STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news
Two drugmakers asked the U.S. Supreme Court to restore mail-order access to the abortion pill mifepristone, after an appeals court suspended deliveries
Read at STAT →
